Supporting commercialization with specialized technologies
Joseph Szczesiul, Director of Technical Services and Patrick Hatem, Vice President of Manufacturing of UPM Pharmaceuticals, have written an article for Pharma's Almanac on supporting commercialization with specialized technologies.
As the complexity of APIs and drug formulations continues to increase, drug manufacturers more frequently need to engage contract development and manufacturing organizations that can support them with specialized technologies from the proof-of-concept stage through clinical trials and on to commercial production.
Many small molecule APIs in the pharmaceutical pipeline today have increased potency. These compounds can affect workers and the environment at very low concentration levels and therefore require special equipment and handling capabilities to ensure proper containment and prevent their release into the air.
UPM Pharmaceuticals has capabilities for processing potent compounds from development to commercial quantities. Manufacturing takes place in glove boxes with table-top equipment at bench scale and moves up to compound-dedicated suites with appropriate air flow controls and outfitted with the necessary full-scale containment equipment.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance